BOVEY TRACEY & CHUDLEIGH PRACTICE — All Prescriptions & Medications — Page 5
Practice Code: L83045 | NEWTON ABBOT, TQ13 9QP
Showing results 201-250 of 705
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Cyclizine hydrochloride | 198 | 8,093 | £300 | +22.7% ▲ |
| Umeclidinium bromide/vilanterol | 195 | 246 | £7.6K | +0.0% vs avg |
| Typhoid | 194 | 194 | £2.0K | +115.4% ▲ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 192 | 224 | £9.8K | +14.8% ▲ |
| Dihydrocodeine tartrate | 192 | 25.6K | £1.7K | -1.7% vs avg |
| Lithium carbonate | 191 | 6,125 | £928 | +50.6% ▲ |
| Pancreatin | 190 | 59.1K | £16.7K | +70.9% ▲ |
| Terbinafine hydrochloride | 187 | 9,023 | £3.5K | +202.5% ▲ |
| 186 | 4,479 | £1.8K | +276.3% ▲ | |
| Clotrimazole | 185 | 1,540 | £1.9K | +67.7% ▲ |
| Verapamil hydrochloride | 182 | 15.5K | £1.8K | +100.6% ▲ |
| Sodium cromoglicate | 181 | 3,374 | £910 | +94.8% ▲ |
| Lymecycline | 174 | 10.4K | £1.2K | +44.7% ▲ |
| Insulin detemir | 172 | 1,402 | £11.8K | +119.6% ▲ |
| Etoricoxib | 170 | 6,400 | £1.3K | +111.0% ▲ |
| Powder extensively hydrolysed formula (0913101) | 168 | 486.0K | £14.0K | +133.2% ▲ |
| Pantoprazole | 167 | 9,730 | £448 | -39.2% ▼ |
| Triptorelin | 167 | 167 | £32.1K | +691.7% ▲ |
| Hydrocortisone | 166 | 37.0K | £41.6K | +96.6% ▲ |
| 166 | 3,246 | £1.6K | +114.7% ▲ | |
| Fusidic acid | 163 | 3,750 | £458 | +27.7% ▲ |
| Rivastigmine | 162 | 5,050 | £4.7K | +135.5% ▲ |
| Indacaterol/glycopyrronium | 161 | 6,710 | £6.9K | +256.6% ▲ |
| Fludrocortisone acetate | 161 | 9,031 | £1.6K | +52.6% ▲ |
| Fluorouracil (Sunscreen) | 160 | 6,295 | £5.0K | +339.3% ▲ |
| 160 | 4,740 | £3.4K | +331.0% ▲ | |
| Biphasic insulin aspart | 158 | 1,795 | £10.5K | +55.6% ▲ |
| Risedronate sodium | 158 | 1,456 | £574 | +30.3% ▲ |
| Celecoxib | 156 | 12.1K | £953 | +136.2% ▲ |
| Tapentadol | 155 | 9,812 | £4.6K | +276.5% ▲ |
| Metronidazole | 155 | 6,830 | £1.8K | +312.5% ▲ |
| Lofepramine hydrochloride | 153 | 8,258 | £4.4K | +411.5% ▲ |
| Nicotine | 153 | 6,118 | £3.9K | +170.9% ▲ |
| Lorazepam | 152 | 7,982 | £2.9K | +6.6% ▲ |
| Biphasic isophane insulin | 152 | 1,445 | £6.0K | +36.2% ▲ |
| Hepatitis A | 150 | 150 | £2.9K | +97.5% ▲ |
| Amiodarone hydrochloride | 148 | 6,550 | £359 | +129.4% ▲ |
| 148 | 1,483 | £626 | +44.9% ▲ | |
| Donepezil hydrochloride | 147 | 6,362 | £255 | -52.4% ▼ |
| 147 | 1,806 | £5.4K | +467.3% ▲ | |
| Nicorandil | 146 | 9,240 | £1.4K | +1.4% vs avg |
| Diphtheria | 146 | 146 | £1.1K | +118.8% ▲ |
| Pramipexole | 145 | 12.9K | £1.8K | +47.7% ▲ |
| Cyanocobalamin | 145 | 10.8K | £1.0K | -58.9% ▼ |
| Ferrous gluconate | 140 | 8,726 | £246 | +192.7% ▲ |
| 139 | 18.0K | £742 | +6.1% ▲ | |
| Tolterodine | 137 | 10.4K | £1.2K | -7.8% ▼ |
| Adrenaline | 136 | 292 | £17.1K | +115.7% ▲ |
| Risperidone | 135 | 9,109 | £2.5K | -46.6% ▼ |
| Sacubitril/valsartan | 133 | 7,756 | £12.7K | -44.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.